Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * | KEGG DRUG * | DrugBank | 指定難病告示番号 * |
1 | Alcoholism |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
2件: DRD1, DRD2 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 | ||
2 | Amphetamine addiction |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
1件: DRD1 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 | ||
3 | Calcium signaling pathway |
2件: DRD1, DRD5 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 |
4 | cAMP signaling pathway |
3件: DRD1, DRD2, DRD5 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 |
5 | Cocaine addiction |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
2件: DRD1, DRD2 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 | ||
6 | Dopaminergic synapse |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 | ||
7 | GABAergic synapse |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | 2件: 201, 206 |
8 | Gap junction |
2件: DRD1, DRD2 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 |
9 | Metabolic pathways |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
10 | Morphine addiction |
1件: DRD1 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | 2件: 201, 206 | ||
11 | Neuroactive ligand-receptor interaction |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | 2件: 201, 206 | ||
12 | Nicotine addiction |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | 2件: 201, 206 |
13 | Parkinson disease |
2件: DRD1, DRD2 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 |
14 | Phenylalanine metabolism |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
15 | Rap1 signaling pathway |
1件: DRD2 | D00059 | Levodopa | 7件: 2, 4, 6, 17, 90, 164, 201 |
16 | Retrograde endocannabinoid signaling |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ | D04282 | Gaboxadol | 2件: 201, 206 |
17 | Serotonergic synapse |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
3件: GABRB1, GABRB2, GABRB3 | D04282 | Gaboxadol | 2件: 201, 206 | ||
18 | Taste transduction |
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 | D04282 | Gaboxadol | 2件: 201, 206 |
19 | Tryptophan metabolism |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |
20 | Tyrosine metabolism |
1件: DDC | D00558 | Carbidopa | 8件: 2, 4, 6, 13, 17, 90, 164, 201 |